Concord Medical Services (CCM) Competitors

$4.74 -0.17 (-3.37%)

Closing price 03:59 PM Eastern

Extended Trading

$4.69 -0.04 (-0.95%)

As of 04:50 PM Eastern

CCM vs. XGN, EUDA, PIII, BMGL, and ACON

Should you be buying Concord Medical Services stock or one of its competitors? The main competitors of Concord Medical Services include Exagen (XGN), EUDA Health (EUDA), P3 Health Partners (PIII), Basel Medical Group (BMGL), and Aclarion (ACON). These companies are all part of the "healthcare" industry.

How does Concord Medical Services compare to Exagen?

Exagen (NASDAQ:XGN) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

: Concord Medical Services has higher revenue and earnings than Exagen.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Exagen $66.57M 1.12 -$19.95M -$0.92 N/A
Concord Medical Services $460.51M 0.04 -$13.27M N/A N/A
: 75.3% of Exagen shares are owned by institutional investors. 12.6% of Exagen shares are owned by insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
: In the previous week, Concord Medical Services had 8 more articles in the media than Exagen. MarketBeat recorded 9 mentions for Concord Medical Services and 1 mentions for Exagen. Exagen's average media sentiment score of 0.50 beat Concord Medical Services' score of 0.15 indicating that Exagen is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Exagen
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Concord Medical Services
0 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Exagen currently has a consensus target price of $9.38, indicating a potential upside of 203.40%. Given Exagen's stronger consensus rating and higher possible upside, research analysts plainly believe Exagen is more favorable than Concord Medical Services.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exagen
1 Sell rating(s)
0 Hold rating(s)

9 Buy rating(s)

0 Strong Buy rating(s)
2.80
Concord Medical Services
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: Concord Medical Services has a net margin of 0.00% compared to Exagen's net margin of -29.97%. Concord Medical Services' return on equity of 0.00% beat Exagen's return on equity.
Company Net Margins Return on Equity Return on Assets
Exagen -29.97% -105.03% -30.10%
Concord Medical Services N/A N/A N/A
: Exagen has a beta of 1.81, suggesting that its share price is 81% more volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -1.09, suggesting that its share price is 209% less volatile than the S&P 500.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exagen	$66.57M	1.12	-$19.95M	-$0.92	N/A
Concord Medical Services	$460.51M	0.04	-$13.27M	N/A	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exagen	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Concord Medical Services	0 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exagen	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Exagen	-29.97%	-105.03%	-30.10%
Concord Medical Services	N/A	N/A	N/A

Summary

Exagen and Concord Medical Services tied by winning 7 of the 14 factors compared between the two stocks.

How does Concord Medical Services compare to EUDA Health?

EUDA Health (NASDAQ:EUDA) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and valuation.

: EUDA Health has higher earnings, but lower revenue than Concord Medical Services.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
EUDA Health $6.82M 6.03 -$2.77M -$2.40 N/A
Concord Medical Services $460.51M 0.04 -$13.27M N/A N/A
: In the previous week, Concord Medical Services had 4 more articles in the media than EUDA Health. MarketBeat recorded 9 mentions for Concord Medical Services and 5 mentions for EUDA Health. EUDA Health's average media sentiment score of 0.23 beat Concord Medical Services' score of 0.15 indicating that EUDA Health is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
EUDA Health
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Concord Medical Services
0 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: 4.4% of EUDA Health shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: EUDA Health has a beta of 0.56, suggesting that its stock price is 44% less volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -1.09, suggesting that its stock price is 209% less volatile than the S&P 500.
: Company Net Margins Return on Equity Return on Assets
EUDA Health N/A N/A N/A
Concord Medical Services N/A N/A N/A
: EUDA Health currently has a consensus target price of $55.00, indicating a potential upside of 237.22%. Given EUDA Health's stronger consensus rating and higher probable upside, equities analysts clearly believe EUDA Health is more favorable than Concord Medical Services.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EUDA Health
2 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
1.67
Concord Medical Services
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	6.03	-$2.77M	-$2.40	N/A
Concord Medical Services	$460.51M	0.04	-$13.27M	N/A	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Concord Medical Services	0 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Concord Medical Services	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

EUDA Health beats Concord Medical Services on 8 of the 11 factors compared between the two stocks.

How does Concord Medical Services compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIII) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and valuation.

: Concord Medical Services has lower revenue, but higher earnings than P3 Health Partners.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
P3 Health Partners $1.46B 0.01 -$147.95M -$45.20 N/A
Concord Medical Services $460.51M 0.04 -$13.27M N/A N/A
: P3 Health Partners currently has a consensus target price of $3.50, indicating a potential upside of 21.11%. Given P3 Health Partners' stronger consensus rating and higher probable upside, equities analysts clearly believe P3 Health Partners is more favorable than Concord Medical Services.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
P3 Health Partners
1 Sell rating(s)
2 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
Concord Medical Services
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: In the previous week, Concord Medical Services had 9 more articles in the media than P3 Health Partners. MarketBeat recorded 9 mentions for Concord Medical Services and 0 mentions for P3 Health Partners. Concord Medical Services' average media sentiment score of 0.15 beat P3 Health Partners' score of 0.00 indicating that Concord Medical Services is being referred to more favorably in the news media.
Company Overall Sentiment
P3 Health Partners Neutral
Concord Medical Services Neutral
: 7.8% of P3 Health Partners shares are owned by institutional investors. 17.8% of P3 Health Partners shares are owned by insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: P3 Health Partners has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -1.09, suggesting that its stock price is 209% less volatile than the S&P 500.
: Concord Medical Services has a net margin of 0.00% compared to P3 Health Partners' net margin of -10.14%. Concord Medical Services' return on equity of 0.00% beat P3 Health Partners' return on equity.
Company Net Margins Return on Equity Return on Assets
P3 Health Partners -10.14% -302.33% -20.72%
Concord Medical Services N/A N/A N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.01	-$147.95M	-$45.20	N/A
Concord Medical Services	$460.51M	0.04	-$13.27M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Overall Sentiment
P3 Health Partners	Neutral
Concord Medical Services	Neutral

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-10.14%	-302.33%	-20.72%
Concord Medical Services	N/A	N/A	N/A

Summary

Concord Medical Services beats P3 Health Partners on 8 of the 14 factors compared between the two stocks.

How does Concord Medical Services compare to Basel Medical Group?

Basel Medical Group (NASDAQ:BMGL) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Basel Medical Group
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Concord Medical Services
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: Company Net Margins Return on Equity Return on Assets
Basel Medical Group N/A N/A N/A
Concord Medical Services N/A N/A N/A
: Basel Medical Group has a beta of 0.07, meaning that its share price is 93% less volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -1.09, meaning that its share price is 209% less volatile than the S&P 500.
: In the previous week, Concord Medical Services had 9 more articles in the media than Basel Medical Group. MarketBeat recorded 9 mentions for Concord Medical Services and 0 mentions for Basel Medical Group. Concord Medical Services' average media sentiment score of 0.15 beat Basel Medical Group's score of 0.00 indicating that Concord Medical Services is being referred to more favorably in the news media.
Company Overall Sentiment
Basel Medical Group Neutral
Concord Medical Services Neutral
: Basel Medical Group has higher earnings, but lower revenue than Concord Medical Services.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Basel Medical Group $8.90M 1.28 -$9.50M N/A N/A
Concord Medical Services $460.51M 0.04 -$13.27M N/A N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
Concord Medical Services	N/A	N/A	N/A

Company	Overall Sentiment
Basel Medical Group	Neutral
Concord Medical Services	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$8.90M	1.28	-$9.50M	N/A	N/A
Concord Medical Services	$460.51M	0.04	-$13.27M	N/A	N/A

Summary

Basel Medical Group and Concord Medical Services tied by winning 3 of the 6 factors compared between the two stocks.

How does Concord Medical Services compare to Aclarion?

Aclarion (NASDAQ:ACON) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

: Aclarion has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -1.09, indicating that its stock price is 209% less volatile than the S&P 500.
: Concord Medical Services has a net margin of 0.00% compared to Aclarion's net margin of -9,517.11%. Concord Medical Services' return on equity of 0.00% beat Aclarion's return on equity.
Company Net Margins Return on Equity Return on Assets
Aclarion -9,517.11% -52.31% -49.79%
Concord Medical Services N/A N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aclarion
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Concord Medical Services
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: In the previous week, Concord Medical Services had 7 more articles in the media than Aclarion. MarketBeat recorded 9 mentions for Concord Medical Services and 2 mentions for Aclarion. Concord Medical Services' average media sentiment score of 0.15 beat Aclarion's score of 0.00 indicating that Concord Medical Services is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aclarion
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Concord Medical Services
0 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Aclarion has higher earnings, but lower revenue than Concord Medical Services.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aclarion $80K 98.40 -$7.23M -$17.01 N/A
Concord Medical Services $460.51M 0.04 -$13.27M N/A N/A
: 7.5% of Aclarion shares are held by institutional investors. 0.8% of Aclarion shares are held by insiders. Comparatively, 46.5% of Concord Medical Services shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	-9,517.11%	-52.31%	-49.79%
Concord Medical Services	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aclarion	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Concord Medical Services	0 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$80K	98.40	-$7.23M	-$17.01	N/A
Concord Medical Services	$460.51M	0.04	-$13.27M	N/A	N/A

Summary

Concord Medical Services beats Aclarion on 7 of the 11 factors compared between the two stocks.

Get Concord Medical Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCM vs. The Competition

Export

Metric	Concord Medical Services	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$20.56M	$4.03B	$6.25B	$22.95B
Dividend Yield	N/A	0.80%	2.73%	4.03%
P/E Ratio	N/A	12.58	29.03	28.57
Price / Sales	0.04	1.21	476.10	23.57
Price / Cash	2.12	18.99	27.62	19.03
Price / Book	0.08	2.35	9.67	4.68
Net Income	-$13.27M	$47.01M	$3.55B	$1.07B
7 Day Performance	34.48%	5.72%	1.75%	0.90%
1 Month Performance	23.34%	4.02%	5.66%	6.56%
1 Year Performance	-29.90%	48.27%	34.42%	31.66%

Concord Medical Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCM Concord Medical Services	0.2633 of 5 stars	$4.74 -3.4%	N/A	N/A	$20.56M	$460.51M	N/A	970	Earnings Report Gap Down High Trading Volume
XGN Exagen	4.0563 of 5 stars	$2.76 +1.1%	$9.38 +239.7%	N/A	$66.38M	$66.57M	N/A	220	Upcoming Earnings
EUDA EUDA Health	2.2877 of 5 stars	$14.49 +20.8%	$55.00 +279.6%	N/A	$36.52M	$4.01M	N/A	2	Earnings Report Gap Down High Trading Volume
PIII P3 Health Partners	1.7363 of 5 stars	$2.80 -3.1%	$3.50 +25.0%	N/A	$20.19M	$1.46B	N/A	500
BMGL Basel Medical Group	0.2134 of 5 stars	$0.56 -10.1%	N/A	N/A	$10.52M	$8.90M	N/A	36	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CCM) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Concord Medical Services (CCM) Competitors

CCM vs. XGN, EUDA, PIII, BMGL, and ACON

How does Concord Medical Services compare to Exagen?

Summary

How does Concord Medical Services compare to EUDA Health?

Summary

How does Concord Medical Services compare to P3 Health Partners?

Summary

How does Concord Medical Services compare to Basel Medical Group?

Summary

How does Concord Medical Services compare to Aclarion?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCM vs. The Competition

Concord Medical Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Concord Medical Services (CCM) Competitors

CCM vs. XGN, EUDA, PIII, BMGL, and ACON

How does Concord Medical Services compare to Exagen?

Summary

How does Concord Medical Services compare to EUDA Health?

Summary

How does Concord Medical Services compare to P3 Health Partners?

Summary

How does Concord Medical Services compare to Basel Medical Group?

Summary

How does Concord Medical Services compare to Aclarion?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCM vs. The Competition

Concord Medical Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools